Home/Filings/4/0001209191-07-006023
4//SEC Filing

Thievon John 4

Accession 0001209191-07-006023

CIK 0001319439other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 3:55 PM ET

Size

25.6 KB

Accession

0001209191-07-006023

Insider Transaction Report

Form 4
Period: 2007-01-29
Thievon John
EVP, Commercial Operations
Transactions
  • Sale

    Common Stock

    2007-01-29$44.84/sh46$2,06357 total
  • Sale

    Common Stock

    2007-01-29$44.73/sh2$891,594 total
  • Sale

    Common Stock

    2007-01-29$44.74/sh369$16,5091,225 total
  • Sale

    Common Stock

    2007-01-29$44.82/sh125$5,603103 total
  • Sale

    Common Stock

    2007-01-29$44.68/sh29$1,2962,822 total
  • Sale

    Common Stock

    2007-01-29$44.69/sh57$2,5472,765 total
  • Sale

    Common Stock

    2007-01-29$44.79/sh171$7,659228 total
  • Sale

    Common Stock

    2007-01-29$44.72/sh770$34,4341,596 total
  • Sale

    Common Stock

    2007-01-29$44.71/sh399$17,8392,366 total
  • Sale

    Common Stock

    2007-01-29$44.75/sh540$24,165685 total
  • Sale

    Common Stock

    2007-01-29$44.77/sh105$4,701551 total
  • Sale

    Common Stock

    2007-01-29$44.78/sh152$6,807399 total
Footnotes (1)
  • [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2006.

Issuer

Adams Respiratory Therapeutics, Inc.

CIK 0001319439

Entity typeother

Related Parties

1
  • filerCIK 0001331752

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 3:55 PM ET
Size
25.6 KB